Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 5/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 0||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Abdominal pain, Arthralgia, Dyspnoea, Fatigue, Headache, Muscle spasms, Muscular weakness, Palpitations, Sleep disorder, Syncope, Cognitive disorder, Postural orthostatic tachycardia syndrome, Tilt table test positive
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: HPV immunisation; Hepatitis A immunisation; Hepatitis B immunistion
Diagnostic Lab Data: POTS during tilt table test
CDC 'Split Type': WAES1512DNK012324
Write-up:Information has been received from Sanofi Pasteur MSD (MFR number# DK-1577272925-2015001423) on 23-DEC-2015. Case received from a physician via health authority on 22-DEC-2015 under reference number DK-DKMA-WBS-0002135 and DK-DKMA-ADR 23278256. A 14-year-old female adolescent patient received GARDASIL, (batch number unknown , Dose 1) via intramuscular route on 06-OCT-2011, GARDASIL, (batch number unknown, Dose 2) via intramuscular route on 14-DEC-2011, GARDASIL, (batch number unknown, Dose 3) via intramuscular route on 02-MAY-2012. Other suspect products included Hepatitis A Virus, (batch number unknown) in 2014 Hepatitis B Virus, (batch number unknown) in 2014. The patient experienced Postural orthostatic tachycardia syndrome on an unknown date, Headache on an unknown date, Joint pain on an unknown date, Syncope on an unknown date, Palpitations on an unknown date, Abdominal pain on an unknown date, Dyspnea on an unknown date, Sleep disorder on an unknown date, Fatigue extreme on an unknown date, Cognitive disorder on an unknown date, Muscular spasm on an unknown date, muscular weakness on an unknown date and Subfebril on an unknown date. A bit uncertain regarding the timing of the progression HPV vaccinated 2011-2012 and hepatitis A abd B summer 2014. A bit uncertain if the symptoms started before the hepatitis vaccination, but at least the symptoms added/worsen the symptoms after hepatitis vaccination POTS with tilt table test: Criteria for POTS Heart rate increases greater than or equal to 30 bpm from supine to standing (10 min) in the absence of orthostatic hypotension (decrease in BP greater than 20/10 mmHg). Symptoms worsen with standing and improved with recumbence, Symptoms last greater than or equal to 6 months. Absence of other overt cause of orthostatic or tachycardia (e.g., active bleeding, acute dehydration, medications) In addition, the Hospital uses further criterion in patients between 12-19 years: requires a heart rate increase of greater than 40 bpm to make the diagnosis, the reasons for this is that young people have stronger physiological heart rate response when standing up. The additional criterion is used to avoid false positives. Other vaccines or medicines: unknown The patient''s outcome was reported as not recovered/not resolved.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166